All Stories

  1. Reply to Takefuji: Beyond linear assumptions in pulmonary function analysis: a methodological critique of veteran health outcome models
  2. Plasma proteomic profiles of lung volume–based phenotypes in tobacco-exposed individuals without spirometric chronic obstructive pulmonary disease
  3. Correction: Self‑report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study
  4. Clinical Utility of Pulmonary Function Testing in Assessing Longitudinal Outcomes of Deployed Veterans with Preserved Spirometry
  5. Indoor Air Pollution, Computed Tomography Airway-to-Lung Ratio and Lung Function Decline: Analyses from SPIROMICS AIR
  6. Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes
  7. The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study
  8. Trends in All-cause Mortality among U.S. Veterans with Sarcoidosis, 2004–2022
  9. Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study
  10. NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids
  11. Effect of twice daily inhaled albuterol on cardiopulmonary exercise outcomes, dynamic hyperinflation, and symptoms in secondhand tobacco-exposed persons with preserved spirometry and air trapping: a randomized controlled trial
  12. Response
  13. Effect of a single one-hour teaching session about environmental pollutants and climate change on the understanding and behavioral choices of adolescents: The BREATHE pilot randomized controlled trial
  14. Screening for Exposure to Beryllium Among US Veterans With a Diagnosis of Sarcoidosis, 2002-2020
  15. Late Breaking Abstract - Lung volumes differentiate emphysema- vs. airway disease-dominant pathologies with distinct clinical features in tobacco-exposed persons with preserved spirometry in SPIROMICS
  16. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
  17. Lung volumes differentiate the predominance of emphysemaversusairway disease phenotype in early COPD: an observational study of the COPDGene cohort
  18. Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019
  19. Self-report Underestimates COPD Exacerbation Frequency but Is Associated With BAL Neutrophilia and Lymphocytosis
  20. Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis
  21. Changes in Lung Volumes with Spirometric Disease Progression in COPD
  22. A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality
  23. Effect of ozone on allergic airway inflammation
  24. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study
  25. NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids
  26. Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD
  27. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume
  28. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study
  29. Laryngeal Hypersensitivity in a Veteran Cohort with Remote Exposure to Tear Gas and Pepper Spray
  30. Smaller Baseline TLC and VC Differentiate Smokers with Preserved Spirometry (GOLD-0) Who Progress to More Severe Spirometric Obstruction (GOLD-2 to GOLD-4 versus GOLD-1): An Analysis of the Department of Veterans Affairs Electronic Health Records
  31. The Epidemiology of Sarcoidosis Among U.S. Veterans, 2000-2020
  32. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD
  33. Effects of short-term increases in personal and ambient pollutant concentrations on pulmonary and cardiovascular function: A panel study analysis of the Multicenter Ozone Study in oldEr subjects (MOSES 2)
  34. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers
  35. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study
  36. Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program
  37. Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease
  38. Polygenic predisposition to venous thromboembolism is associated with increased COVID-19 positive testing rates
  39. Effect of Ozone on Allergic Airway Inflammation
  40. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study
  41. Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort
  42. Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers
  43. Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument
  44. Elastin degradation markers are elevated in never-smokers with past history of prolonged exposure to secondhand tobacco smoke and are inversely associated with their lung function
  45. Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS
  46. Actigraphy informs distinct patient-centered outcomes in Pre-COPD
  47. A MUC5Bgene polymorphism, rs35705950-T, confers protective effects in COVID-19 infection
  48. Altitude effect on COPD in SPIROMICS cohort
  49. Classification of lung function trajectories in SPIROMICS
  50. Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS
  51. Bronchodilator responsiveness over time in SPIROMICS: Clinical characteristics
  52. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study (Preprint)
  53. Mechanism of control of the near-wall turbulence using a micro-cavity array
  54. Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids’ immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression
  55. Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function
  56. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers (Preprint)
  57. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume
  58. Actigraphy Informs Distinct Patient-Centered Outcomes in Pre-COPD
  59. Actigraphy Informs of Distinct Patient-Centered Outcome Domains in Obstructive Lung Diseases Beyond That Measured by Respiratory Questionnaires, Lung Function, or Exercise Testing
  60. Assessment of "Percent Functional Small Airways Disease" by Parametric Response Mapping as a Potential Radiographic Biomarker of Deployment-Related Constrictive Bronchiolitis
  61. COVID-19 Infection Among Airborne Hazards Open Burn Pit Registry Participants Utilizing the VA
  62. Secondhand Smoke Alters Alveolar Macrophage Gene Expression
  63. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
  64. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study (Preprint)
  65. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers
  66. Lung Volumes Changes Across GOLD Stages of COPD
  67. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease
  68. Actigraphy provides additional patient-centered outcome domains beyond those measured by survey questionnaires in COPD
  69. Do Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary Function?
  70. Air Trapping in Pre-COPD Contributes to Abnormal Cardiovascular Response to Exercise
  71. Association Between SVC-FVC and Clinical, Functional, and Radiologic Features in Obstructive Lung Disease
  72. Current Smoking Down-Regulates Specific Alveolar Macrophage Host Defense Gene Expression Pathways
  73. Elastin Degradation Markers Are Elevated in Never-Smokers with Past History of Prolonged Exposure to Secondhand Tobacco Smoke and Are Inversely Associated with Their Lung Function
  74. Examination of Insomnia and Other Sleep Conditions Among Deployed US Service Members
  75. FEV1SVC Ratio Below 0.7 Is Associated with Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers with Normal Spirometry
  76. Intermediate (CD14++ CD16+) Monocytes Correlate with Parametric Response Mapping of Functional Small Airways Disease: Spiromics Immunophenotyping Sub-Study
  77. Lung Volumes Differences Across GOLD Stages of COPD in VA Electronic Health Records, COPDGene, and SPIROMICS
  78. Patient-Reported Clinical Variables Associated with Significant Air Trapping in Smokers: An Analysis of the SPIROMICS Cohort
  79. Performance of Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers
  80. Self-Reported Sleep Apnea Among Female Us Service Members in the Airborne Hazard Open Burn Pit Registry
  81. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort
  82. Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD
  83. Military Burn Pits
  84. <p>Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]</p>
  85. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort
  86. Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
  87. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers
  88. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
  89. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
  90. Patterns of development of airflow limitation in smokers with preserved spirometry and air trapping phenotype in COPDGene
  91. Inspiratory capacity is associated with dyspnea, exercise capacity, and survival in COPD
  92. Lung volume comparisons between spirometry and computed tomography in SPIROMICS
  93. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES)
  94. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS
  95. Changes in Lung Volumes Across GOLD Stages of COPD: Implications for Mechanisms of Air Trapping
  96. Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score and Palliative Care Referrals in Patients with Chronic Obstructive Pulmonary Disease
  97. Novel Multiplexed Plasma Biomarkers and Clinical Factors Augment Risk Assessment for Indeterminate Pulmonary Nodules in Former Smokers
  98. Radiographic Lung Volumes Predict Progression to COPD in Smokers with Preserved Spirometry in SPIROMICS
  99. Unsupervised Clustering Reveals Distinct Macrophage Phenotypes Associated with COPD and COPD Exacerbation
  100. Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
  101. Back to the Box: Using Lung Volumes to Predict Susceptibility to Develop Chronic Obstructive Pulmonary Disease among Smokers
  102. Inflammatory Phenotypes Associated with Chronic Obstructive Pulmonary Disease Increase Susceptibility to Exacerbation. Lessons from Single Cell Analysis of Lung Macrophages
  103. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)
  104. MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay
  105. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial
  106. Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD
  107. Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study
  108. Lung volume indices predict morbidity in smokers with preserved spirometry
  109. Marijuana Use, Respiratory Symptoms, and Pulmonary Function
  110. The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk
  111. Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction
  112. Increasing the Resolution of Chronic Obstructive Pulmonary Disease Definition. Lessons from a Cohort with Remote but Extensive Exposure to Secondhand Tobacco Smoke
  113. Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations
  114. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization
  115. Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay
  116. Respiratory Responses to Ozone Exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)
  117. Diagnosing Chronic Obstructive Pulmonary Disease Among Afghanistan and Iraq Veterans: Veterans Affair's Concordance With Clinical Guidelines for Spirometry Administration
  118. Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics
  119. Air trapping is associated with exercise capacity in persons without overt obstructive lung disease
  120. Asthma-COPD Overlap Syndrome- an Underdiagnosed Phenotype in Heavy Smokers
  121. Remote secondhand smoke exposure is associated with progressive airflow limitation during exercise
  122. Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects
  123. Inflammatory and Repair Pathways Induced in Human Bronchoalveolar Lavage Cells with Ozone Inhalation
  124. Ozone inhalation leads to a dose-dependent increase of cytogenetic damage in human lymphocytes
  125. IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction
  126. Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis
  127. Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction
  128. Identification Of Biomarkers To Monitor The Activity Of STX-100, A Humanized Anti-±v²6 Antibody, In A Phase 2a Trial In Idiopathic Pulmonary Fibrosis
  129. Oxidative Injury Due to Inhalation of Ozone Causes Dose-Dependent Cytogenetic Damage in Peripheral Blood Lymphocytes
  130. Reduced Exercise Tolerance And Pulmonary Capillary Recruitment With Remote Exposure To Secondhand Tobacco Smoke
  131. Short-Term Exposure To Ozone Causes A Dose-Dependent Reduction In Heart-Rate Variability
  132. Reduced Exercise Tolerance and Pulmonary Capillary Recruitment with Remote Secondhand Smoke Exposure
  133. Effects of Exercise on Systemic Inflammatory, Coagulatory, and Cardiac Autonomic Parameters in an Inhalational Exposure Study
  134. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population
  135. Secreted Osteopontin Is Highly Polymerized in Human Airways and Fragmented in Asthmatic Airway Secretions
  136. PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice
  137. HIV-1 NEF In HIV-Associated Pulmonary Hypertension: Are There Lung-Specific Nef Signature Sequences?
  138. Low Prevalence of Chronic Beryllium Disease Among Workers at a Nuclear Weapons Research and Development Facility
  139. Effect Of Exposure To Ambient Levels Of Ozone On Systemic Inflammation And Coagulation
  140. Pulmonary Function Abnormalities in Never-Smoking Flight Attendants Exposed to Secondhand Tobacco Smoke in the Aircraft Cabin
  141. Osteopontin Knockout Mice Show Diminished Airway Hyperreactivity Despite Increased Eosinophilic Inflammation and IgE Production in an Experimental Model of Allergic Asthma.
  142. Osteopontin Knockout Mice Show Diminished Airway Remodeling in Response to Chronic Exposure to Ozone.
  143. Osteopontin Level in Induced Sputum Is Associated with FEV1in Asthmatic Subjects.
  144. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Decreased Lung Function.
  145. Is There an Association Between Lifetime Cumulative Exposure and Acute Pulmonary Responses to Ozone?
  146. Effects of Chronic and Acute Ozone Exposure on Lipid Peroxidation and Antioxidant Capacity in Healthy Young Adults
  147. Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes
  148. Cytogenetic damage in buccal epithelia and peripheral lymphocytes of young healthy individuals exposed to ozone
  149. Effects of Nitrogen Dioxide on Allergic Airway Responses in Subjects With Asthma
  150. Repeated Exposure to Ozone Increases Alveolar Macrophage Recruitment into Asthmatic Airways
  151. Sputum Induction and Bronchoscopy for Assessment of Ozone-Induced Airway Inflammation in Asthma
  152. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits
  153. 765-2 Dietary L-Arginine Attenuates Macrophage Infiltration and Intimal Hyperplasia After Balloon Injury
  154. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor